PRTC News and Press, PureTech Health plc From 05/21/24

VE303 is an orally administered, potential first-in-class live biotherapeutic product candidate being developed to prevent recurrence of Clostridioides difficile infection (CDI) PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biother...

Notice of General Meeting PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its propo...

SPT-300 demonstrated nine times greater allopregnanolone exposure in humans dosed orally than published data for oral allopregnanolone, 1 validating Glyph™ platform’s ability to enhance oral bioavailability In a Phase 2a trial, SPT-300 2 substantially reduced str...

Denice Torres, J.D., former Board Member of Karuna Therapeutics and accomplished healthcare executive at Johnson & Johnson, Janssen Neuroscience and Eli Lilly, appointed to Seaport Board of Directors Eric Green, MBA, former development and commercialization leader at Alnylam Pharmaceu...

2024-04-27 20:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Morgan Advanced Materials Plc (MCRUF) is expected to report for Q4 2023 Security Federal Corp (SFDL) is expected to report for Q1 2024 Bank of the James Financial Group Inc. (BOTJ) is expected to report for Q1 2024 OMV AG (OMVJF) is expected to report $1.91 for Q1 2024 Pola Orbis ...

PureTech Health plc (PRTC) is expected to report for Q4 2023

2024-04-25 23:56:07 ET PureTech Health plc (PRTC) Q4 2023 Earnings Conference Call April 25, 2024 09:00 ET Company Participants Allison Mead Talbot - Head, Communications Bharatt Chowrira - Chief Executive Officer Eric Elenko - Co-Founder and President Chip S...

2024-04-25 06:41:37 ET More on PureTech PureTech Health: Repeat What Works PureTech announces $100M capital return through tender offer Seeking Alpha’s Quant Rating on PureTech Historical earnings data for PureTech Financial information for Pur...

Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs, 1 launch of two new Founded Entities, 2 including a $100 million Series A financing for Seaport, and the $14 billion acquisition of Karuna by Bristol Myers Squibb Robust bala...